WT
RPRX icon

Whittier Trust’s Royalty Pharma RPRX Stock Holding History

Whittier Trust’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-242
Closed -$8.72K – 1564
2025
Q2 		$8.72K Hold
242
– – ﹤0.01% 1259
2025
Q1 		$7.53K Hold
242
– – ﹤0.01% 1260
2024
Q4 		$6.17K Sell
242
-242
-50% -$6.42K ﹤0.01% 1334
2024
Q3 		$13.7K Hold
484
– – ﹤0.01% 1207
2024
Q2 		$12.8K Buy
+484
New +$13.4K ﹤0.01% 1210
2021
Q2 		– Sell
-53
Closed -$2K – 1554
2021
Q1 		$2K Buy
+53
New +$2.51K ﹤0.01% 1457

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Whittier Trust's RPRX Position: Q3 2025 in Review

Whittier Trust sold out of Royalty Pharma (RPRX) in Q3 2025, closing a stake of 242 shares — an estimated $8.72K sold.

Whittier Trust first reported a position in RPRX in Q1 2021 and held it in 6 quarters. The position peaked at $13.7K in Q3 2024. 487 funds tracked by Wall St. Rank hold RPRX as of Q3 2025.

  • Whittier Trust reported no remaining Royalty Pharma position as of Q3 2025 after selling out during the quarter.
  • Whittier Trust sold 242 Royalty Pharma shares in Q3 2025, an estimated $8.72K.
  • Whittier Trust first reported a position in Royalty Pharma in Q1 2021 and held it in 6 quarters.
  • Whittier Trust's Royalty Pharma position peaked at $13.7K in Q3 2024.
  • 487 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2025.

Based on Whittier Trust's 13F filing for Q3 2025, filed 31 Oct 2025.